Free Trial

Johnson Matthey (LON:JMAT) Given New GBX 1,950 Price Target at Berenberg Bank

Johnson Matthey logo with Basic Materials background

Johnson Matthey (LON:JMAT - Get Free Report) had its price objective raised by equities researchers at Berenberg Bank from GBX 1,800 ($24.31) to GBX 1,950 ($26.34) in a note issued to investors on Monday, MarketBeat.com reports. The brokerage currently has a "hold" rating on the stock. Berenberg Bank's price target would indicate a potential upside of 6.04% from the company's current price.

Johnson Matthey Stock Performance

JMAT stock traded down GBX 8 ($0.11) during mid-day trading on Monday, hitting GBX 1,839 ($24.84). 379,849 shares of the company were exchanged, compared to its average volume of 2,137,298. The business has a 50 day simple moving average of GBX 1,739.88 and a 200-day simple moving average of GBX 1,487.04. The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 62.73. The stock has a market capitalization of £3.08 billion, a PE ratio of 31.25, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. Johnson Matthey has a 1-year low of GBX 1,131 ($15.28) and a 1-year high of GBX 1,901 ($25.68).

Johnson Matthey (LON:JMAT - Get Free Report) last released its quarterly earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) earnings per share for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. On average, equities analysts forecast that Johnson Matthey will post 173.4112903 earnings per share for the current year.

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.

Read More

Should You Invest $1,000 in Johnson Matthey Right Now?

Before you consider Johnson Matthey, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.

While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines